Wednesday, June 10, 2026

biotech Β· Essential Tremor Β· Systemic Lupus Erythematosus

Chongqing Precision Biotech

Chongqing Precision Biotech clinical programs β€” 49 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

ι‡εΊ†εΈ‚εˆ›δΈšε€§ι“ι«˜η§‘εˆ›δΈšε›­Aζ ‹, Chongqing, CN HQ
2016 Founded
5 Employees
NMPA registrant Type
Company details
Status
Public
HQ
ι‡εΊ†εΈ‚εˆ›δΈšε€§ι“ι«˜η§‘εˆ›δΈšε›­Aζ ‹, Chongqing, CN
Founded
2016
Employees
5
Programs
109
Drugs
57
Patents
158
Intelligence Β· Clinical Programs

Chongqing Precision Biotech projects

49 ClinicalTrials.gov programs sponsored by Chongqing Precision Biotech.

Chongqing Precision Biotech has 49 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 2 of 2
  1. pCAR-19B cells

    Chongqing Precision Biotech Co., Ltd

    Acute Lymphoblastic Leukemia, in Relapse

    phase 1 mab active

    1 trial

Frequently asked questions

How many clinical projects does Chongqing Precision Biotech have?

49 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.